Pizcueta P - Search Results

1

Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.

Garcia-Pagán JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodés J. Garcia-Pagán JC, et al. Among authors: pizcueta p. Hepatology. 1990 Feb;11(2):230-8. doi: 10.1002/hep.1840110212. Hepatology. 1990. PMID: 2307401

2

Pathophysiology of portal hypertension.

Bosch J, Pizcueta P, Feu F, Fernández M, García-Pagán JC. Bosch J, et al. Among authors: pizcueta p. Gastroenterol Clin North Am. 1992 Mar;21(1):1-14. Gastroenterol Clin North Am. 1992. PMID: 1568769 Review.

3

Effects of propranolol on gastric microcirculation and acid secretion in portal hypertensive rats.

Piqué JM, Pizcueta P, Pérez Ayuso RM, Bosch J. Piqué JM, et al. Among authors: pizcueta p. Hepatology. 1990 Sep;12(3 Pt 1):476-80. doi: 10.1002/hep.1840120305. Hepatology. 1990. PMID: 2401453

4

Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat.

García-Pagán JC, Fernández M, Bernadich C, Pizcueta P, Piqué JM, Bosch J, Rodés J. García-Pagán JC, et al. Among authors: pizcueta p. Am J Physiol. 1994 Dec;267(6 Pt 1):G984-90. doi: 10.1152/ajpgi.1994.267.6.G984. Am J Physiol. 1994. PMID: 7810666

5

Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis.

García-Pagán JC, Feu F, Luca A, Fernández M, Pizcueta P, Bosch J, Rodés J. García-Pagán JC, et al. Among authors: pizcueta p. J Hepatol. 1994 Jun;20(6):792-6. doi: 10.1016/s0168-8278(05)80151-5. J Hepatol. 1994. PMID: 7930480 Clinical Trial.

6

Neonatal capsaicin treatment does not prevent splanchnic vasodilatation in portal-hypertensive rats.

Fernández M, Casadevall M, Schuligoi R, Pizcueta P, Panés J, Barrachina MD, Donnerer J, Piqué JM, Esplugues JV, Bosch J, et al. Fernández M, et al. Among authors: pizcueta p. Hepatology. 1994 Dec;20(6):1609-14. doi: 10.1002/hep.1840200634. Hepatology. 1994. PMID: 7982662

7

New approaches in the pharmacologic treatment of portal hypertension.

Bosch J, García-Pagán JC, Feu F, Luca A, Fernández M, Pizcueta P, Rodés J. Bosch J, et al. Among authors: pizcueta p. J Hepatol. 1993;17 Suppl 2:S41-5. doi: 10.1016/s0168-8278(05)80455-6. J Hepatol. 1993. PMID: 8098342 Review.

8

Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis.

García-Pagán JC, Salmerón JM, Feu F, Luca A, Ginés P, Pizcueta P, Claria J, Piera C, Arroyo V, Bosch J, et al. García-Pagán JC, et al. Among authors: pizcueta p. Hepatology. 1994 May;19(5):1095-9. doi: 10.1002/hep.1840190506. Hepatology. 1994. PMID: 8175131

9

Impaired function of pancreatic islets from rats with portal hypertension resulting from cirrhosis and partial portal vein ligation.

Gomis R, Fernández-Alvarez J, Pizcueta P, Fernández M, Casamitjana R, Bosch J, Rodés J. Gomis R, et al. Among authors: pizcueta p. Hepatology. 1994 May;19(5):1257-61. Hepatology. 1994. PMID: 8175150

10

Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.

Fernández M, Pizcueta P, García-Pagán JC, Feu F, Cirera I, Bosch J, Rodés J. Fernández M, et al. Among authors: pizcueta p. Hepatology. 1993 Aug;18(2):389-93. Hepatology. 1993. PMID: 8340068

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters